October 15, 1998 |
Luther Medical Products Inc., a Tustin-based manufacturer of catheter systems, said Wednesday it agreed to be acquired by New Jersey-based Becton Dickinson and Co., a maker of medical supplies, for about $16.3 million, or $4.62 a share. Luther's stock surged 36%, or $1.03 a share, to $3.91. Nearly 426,000 shares changed hands, more than 20 times the average daily volume over the last three months.
September 18, 1998
Luther Medical Products Inc.'s stock moved up 31.5% Thursday after the Tustin company reported that it narrowed its losses and increased its revenue for the year. Luther's shares rose 63 cents to $2.63. Earlier in the month, the stock had traded at a 52-week low of $1.31.
August 21, 1998 |
Luther Medical Products Inc. said it has received approval from the Japanese Ministry of Health to sell its neonatal product range in Japan. The Tustin company's stock rose 16%, or 31 cents a share, to close at $2.19. Luther Medical, which designs and makes intravenous catheter systems, said it plans to deliver the first shipment of about 3,000 units to Japan in September.
April 23, 1998
Luther Medical Products Inc.: The Tustin designer and manufacturer of catheter systems said it lost $41,833, or 1 cent a share, for the third fiscal quarter, contrasted with profit of $32,460, or 1 cent a share, for the comparable 1997 period. Revenue for the quarter ended March 31 declined 13% to $1.3 million from $1.5 million. For the nine months, the company narrowed its net loss to $381,923, or 12 cents a share, from a year-earlier net loss of $598,170, or 18 cents a share.
October 5, 1997
Luther Medical Products Inc., which designs and manufactures catheter systems, reported a net loss of $730,026, or 23 cents a share, for the fiscal year ended June 30, compared with a net loss of $608,655, or 20 cents a share, for the prior year. Revenue increased 38% to $5.5 million from $4 million. For the fourth quarter, the company posted a net loss of $131,856, or 4 cents a share, compared with a year-earlier net loss of $222,079, or 7 cents a share. Revenue rose 23% to $1.